US Medicare Inflation Rebate: Limited Relief For Drugs In Shortage
Executive Summary
CMS is updating its guidance for manufacturers on calculating inflation penalties enacted as part of the Inflation Reduction Act. The agency is outlining a policy to provide some rebate relief for drugs in shortage – but only limited relief for a short time.